Rezo Therapeutics
Rezo Therapeutics is a San Francisco (Mission Bay) biopharmaceutical company spun out of the Quantitative Biosciences Institute (QBI) at UCSF, co-founded by Nevan Krogan, that is building a disease-agnostic network-biology drug discovery platform. Its "sequence to systems to drugs" approach integrates proteomics, human genetics, structural biology, medicinal chemistry, bioinformatics and machine learning to construct comprehensive maps of molecular disease networks and identify novel, druggable targets for precision therapeutics, with an initial focus on oncology. The company launched in November 2022 with a $78M Series A led by SR One, a16z Bio + Health and Norwest Venture Partners, and appointed Derek Hicks as chief executive officer in August 2025. Rezo is a therapeutics developer rather than a software vendor: its computational platform is internal R&D tooling, and the company publishes no public API, SDK, developer portal or machine-readable contract of any kind.
Rezo Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Drug Discovery, and Oncology.
Rezo Therapeutics’ developer surface includes engineering blog and 14 more developer resources.
Kin Score
Standards implemented 1
Standards this provider implements or carries. De facto ones are profiled and measured by the API Commons; formal ones come from the standards directory and are linked by the provider's own tags. The evidence column says how each claim was established — not that it was made.
Terms of Service 1
What its API terms permit and prohibit, quoted from its own page.
Privacy & Data 1
Its role, the data it processes, retention and transfers, quoted from its own privacy page.
Eligibility 1
Who may sign up and where, quoted from its own terms.
Rezo Therapeutics
3 quoted statements, read from Rezo Therapeutics's own page on 2026-11-10.
ELIGIBILITYAI Preferences 1
Its stance on AI training, inference and agents, quoted from its own pages.
Data License 1
How its data and outputs may be reused, quoted from its own terms.
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Documentation 1
Reference material describing how the API behaves
Access & Security 1
Authentication, authorization, and security posture
Commercial 4
Pricing, plans, and the legal terms of use
Company 6
The organization behind the API
Other 3
Properties that don't map to a standard resource type
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.